急性虚血性脳卒中に対するエダラボンとアルガトロバンの脳卒中治療研究

基本情報

NCT ID

NCT00153946

ステータス

完了

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

814

治験依頼者名

Combination Therapy for Acute Ischemic Stroke Study Group

概要

Edaravone, a free radical scavenger, is a novel neuroprotective agent, and argatroban is a selective thrombin inhibitor. Both the drugs were approved by the Japanese Government, and have frequently been used for the treatment of acute brain infarction in Japan. The effect of combination therapy of these drugs, however, has not yet been elucidated. This study will test the safety and efficacy of the combination therapy with these agents in patients with acute non-cardioembolic and non-lacunar ischemic stroke.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)